Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2010 1
2015 2
2019 1
2020 2
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

6 results
Results by year
Filters applied: . Clear all
Page 1
Long-term use of ticagrelor in patients with prior myocardial infarction.
Bonaca MP, Bhatt DL, Cohen M, Steg PG, Storey RF, Jensen EC, Magnani G, Bansilal S, Fish MP, Im K, Bengtsson O, Oude Ophuis T, Budaj A, Theroux P, Ruda M, Hamm C, Goto S, Spinar J, Nicolau JC, Kiss RG, Murphy SA, Wiviott SD, Held P, Braunwald E, Sabatine MS; PEGASUS-TIMI 54 Steering Committee and Investigators. Bonaca MP, et al. N Engl J Med. 2015 May 7;372(19):1791-800. doi: 10.1056/NEJMoa1500857. Epub 2015 Mar 14. N Engl J Med. 2015. PMID: 25773268 Free article. Clinical Trial.
[Argentine Consensus in effective management of anticoagulation clinics for the use of vitamin k antagonists].
Ceresetto JM, Duboscq C, Korin J, Fondevila C, Casais P, Rossi A, Scazziota A, Martinuzzo M, Aris Cancela ME, Rosa C, Pombo G, Guimelli C, Adamczuk Y, Martí A, Penchasky D, Riveros D, Puente D, Celebrin L, Molnar S, Meschengieser S, Castro Ríos M, Blanco A, Hendler H, Brodsky A, Sánchez Luceros A, Negri Aranguren P, Fedele JL, Merlo C, Raña P, Gumpel C, Colorio C, Grand B, Canónico V, Rossi E, Colimodio P, Orlando S, Fassi D, Arias M, Viudez L, Farreras R, Martínez P, Ferro H, Casali C, Baques A, Arbesú G, Viñuales S, Medina F, Cortés V, Gallo MDC, Ehelou L, Barrera L, Rey I, de Larrañaga G, Figueroa F, Vilaseca A, Kuri I, Maneyro A, Otaran M, Xavier DL, Garbiero S, Salviú J, Fontenla P, Eckhardt A, Bomparola C, Fornasiero L. Ceresetto JM, et al. Medicina (B Aires). 2020;80 Suppl 4:1-26. Medicina (B Aires). 2020. PMID: 32897867 Free article. Spanish.
Platelets enhance tissue factor protein and metastasis initiating cell markers, and act as chemoattractants increasing the migration of ovarian cancer cells.
Orellana R, Kato S, Erices R, Bravo ML, Gonzalez P, Oliva B, Cubillos S, Valdivia A, Ibañez C, Brañes J, Barriga MI, Bravo E, Alonso C, Bustamente E, Castellon E, Hidalgo P, Trigo C, Panes O, Pereira J, Mezzano D, Cuello MA, Owen GI. Orellana R, et al. BMC Cancer. 2015 Apr 15;15:290. doi: 10.1186/s12885-015-1304-z. BMC Cancer. 2015. PMID: 25886038 Free PMC article.
Effect of rosiglitazone on progression of coronary atherosclerosis in patients with type 2 diabetes mellitus and coronary artery disease: the assessment on the prevention of progression by rosiglitazone on atherosclerosis in diabetes patients with cardiovascular history trial.
Gerstein HC, Ratner RE, Cannon CP, Serruys PW, García-García HM, van Es GA, Kolatkar NS, Kravitz BG, Miller DM, Huang C, Fitzgerald PJ, Nesto RW; APPROACH Study Group. Gerstein HC, et al. Circulation. 2010 Mar 16;121(10):1176-87. doi: 10.1161/CIRCULATIONAHA.109.881003. Epub 2010 Mar 1. Circulation. 2010. PMID: 20194881 Clinical Trial.